Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
about
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaEQ-5D in skin conditions: an assessment of validity and responsivenessAn educational review of the statistical issues in analysing utility data for cost-utility analysis.Psychometric properties of the incontinence utility index among patients with idiopathic overactive bladder: data from two multicenter, double-blind, randomized, Phase 3, placebo-controlled clinical trials.Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.Examining the incremental impact of long-standing health conditions on subjective well-being alongside the EQ-5D.Development of a Patient-Reported Palliative Care-Specific Health Classification System: The POS-EEstimating a preference-based index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): valuation of CORE-6DPatient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death.Development and Initial Validation of the Satisfaction and Recovery Index (SRI) for Measurement of Recovery from Musculoskeletal TraumaDevelopment of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic ModuleHow is the most severe health state being valued by the general population?An exploratory study to test the impact on three "bolt-on" items to the EQ-5D.Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome.Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review.Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility spaceDevelopment of a preference-based index from the National Eye Institute Visual Function Questionnaire-25.Mindfulness for the self-management of fatigue, anxiety, and depression in women with metastatic breast cancer: a mixed methods feasibility studyA Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health.A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes.An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment.Preference-based disease-specific health-related quality of life instrument for glaucoma: a mixed methods study protocolDeveloping a dementia-specific health state classification system for a new preference-based instrument AD-5D.Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trialsCondition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?Methodological developments in randomized controlled trial-based economic evaluations.How Well Do the Generic Multi-attribute Utility Instruments Incorporate Patient and Public Views Into Their Descriptive Systems?Reducing outcome measures in mental health: a systematic review of the methods."Naming and Framing": The Impact of Labeling on Health State Values for Multiple Sclerosis.Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.Effect of adding a sleep dimension to the EQ-5D descriptive system: a "bolt-on" experiment.Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countries.Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy.Developing preference-based measures for diabetes: DHP-3D and DHP-5D.A comparison of methods for converting DCE values onto the full health-dead QALY scale.Involving Members of the Public in Health Economics Research: Insights from Selecting Health States for Valuation to Estimate Quality-Adjusted Life-Year (QALY) Weights.
P2860
Q24202071-899B29B3-07AF-4AF2-A946-D8AE7A402CB4Q27011276-1B1AC093-AAD4-4037-ABB1-01D1908ACB93Q30884759-ACAC124A-D6BB-4ECA-80CF-AE9076886643Q30984304-8167E6C5-807B-4979-9308-19C13604B7E3Q33557934-C64E2A50-9566-4997-BCD4-2B1B2841AB7AQ33613953-DEFF4CCB-7023-4E7F-9EAB-3CD5BACF687CQ33650080-428C2EB1-3833-48D3-8D5D-BDBE53110CF0Q33937763-543310E2-5564-4DFD-B6A0-84058367C23AQ34235050-34FC377D-CEF5-4BE8-81D9-59EEEDA299A8Q34329717-EE8632FC-0EC5-476C-A2B7-1272FCCBCA9DQ34334025-78B9CDCF-6ABE-4C90-84A6-C9A29DD40DDDQ34416777-10C25802-A903-44A3-8507-9E3411C928C8Q35024619-157A6E39-3CEB-4F52-9E99-D00342C02E96Q35050550-69E83F6F-0DB6-4C6C-A3BF-D22F49344B15Q35059037-D50FD3B7-59A0-4900-B5E8-8A54D3735BF3Q35159488-C5982854-1D24-461F-A636-3CF8657E93C8Q35170913-7086CA27-D49E-414F-8F7F-31058E67EF0FQ35330774-4352E9DD-AA3A-4F43-8E92-8137F7C0FA0DQ35906213-A29FA2C2-7117-46CC-9E7B-F0A0EC8173BAQ36336056-8A086B09-B939-4150-8A4E-76976E583A31Q37369035-86DD21FF-90F9-458F-9EE2-75E51EDFE344Q37454711-B220D9F4-C6D0-47A2-8F63-F2F02F1910E7Q37604991-F3F8B183-84C6-4629-B7A7-25C04463F908Q37615658-B396CA58-392F-4AD6-99A2-AB3109899CE9Q37733475-622DA591-7983-49AB-A5E2-E5B460846BDEQ38212030-BB733D9F-3F62-4861-B508-000E37521FF4Q38245370-37A94D7C-3B5D-4DD1-8A4E-56C0350C5990Q38348452-6E0254ED-5D17-4B4A-BA78-B21989366799Q38658379-4868EE6C-8038-4322-9EE6-7B1B6CF0FFB2Q38772696-9F597699-FA9E-4A71-A3FD-25C9AEE0A1D5Q38989994-1EC6A64E-DF93-4259-A169-A60B291CFC17Q39346865-91C6342C-8B6B-40EB-8E49-E104BBF75873Q45164795-B8F3A2F0-206C-4EDC-93B0-0D01218F3F18Q47261501-521553AF-BEED-4DBE-A9A2-9E37DD93DF78Q47547664-285C98F1-B6F9-4BF9-A1F7-8DD508E5F9B7Q47570767-BCD677C3-5027-4C0F-8263-DF31D2F2EBB3Q47629526-2D3BC14A-B9F9-4D1A-BBC5-0E2E232E566CQ47882613-F5763876-474F-4C0D-A5F9-E7E60526E041Q48016530-F8EAEA1D-C6C1-4878-914D-6D8D52C02841Q48164166-9F8E1C58-6DA7-446B-B44F-63F7EB2C047E
P2860
Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Developing and testing methods ...... nt-based measures of outcome).
@en
type
label
Developing and testing methods ...... nt-based measures of outcome).
@en
prefLabel
Developing and testing methods ...... nt-based measures of outcome).
@en
P50
P356
P1476
Developing and testing methods ...... ent-based measures of outcome)
@en
P2093
P356
10.3310/HTA16320
P577
2012-07-01T00:00:00Z